Search results
- Recent studies, both nationally and at Michigan Medicine, report that alcohol, cannabis and nicotine vaping are the most commonly used substances among teens. Aside from cannabis and prescription drug misuse, teens report relatively low use of illicit substances. Despite this, teen drug overdose deaths have been on the rise in recent years.
medicine.umich.edu › dept › psychiatry
- MPR News
Youth Mental Health panel talks cell phone bans, rural needs
The Center for Rural Policy and Development recently released a new report on youth mental health, highlighting the challenges and needs for...
56 minutes ago
- AZCentral | The Arizona Republic via Yahoo
Preventing suicide in Native communities requires breaking the stigma, health experts say
Teen Lifeline’s 24/7 crisis line serves teens at 602-248-8336 for Maricopa County and 1-800-248-8336...
54 minutes ago
Mar 1, 2024 · Adolescents high in impulsivity, hopelessness, thrill-seeking, or anxiety sensitivity face higher risks of mental health difficulties and substance use, so the personalized material helps them practice healthy coping based on their personality type.
People also ask
How does substance use affect youth?
Why should youth be concerned about drug abuse?
Are youth at risk for a substance use disorder?
Nov 7, 2022 · This review article sheds light on ‘substance abuse’ amongst adolescents as an issue of public health significance, its determinants, and its implications on the health and well-being of adolescents.
- 10.7759/cureus.31193
- 2022/11
- Cureus. 2022 Nov; 14(11): e31193.
Source: Division of Adolescent and School Health, National Center for Chronic Disease Prevention and Health Promotion. Learn why substance use is a problem for teens, what puts teens at risk, and how to prevent use of high-risk drugs like heroin, opioids, and meth.
- Disclaimer
- Public Domain Notice
- Electronic Access
- Abstract
- Evidence-Based Resource Guide Series Overview
- Marijuana Types1
- Learn more about the diferent types of marijuana
- Risk and Protective Factors for Youth Marijuana Use
- Professional Organization Statements on Marijuana and Youth
- What Research Tells Us
- Comprehensive Approaches to Prevention
- Research Opportunity
- Youth Substance Use Prevention Programs With Marijuana-Related Outcomes
- Community-Level Interventions/ Environmental Strategies
- Banning Products and Packaging That Attract Youth
- Using the Strategic Prevention Framework
- Challenge
- Strategy
- Challenge
- Strategies
- Key Considerations for Implementing Programs to Prevent Marijuana Use Among Youth
- Challenge
- Challenge
- Strategies
- Challenge
- Strategy
- Key Considerations for Implementing Policies to Address Marijuana Use Among Youth
- Challenge
- Challenge
- Strategy
- Strategy
- Strategies
- Implementation Guides and Manuals
- Programs
- Regulating Marijuana Prices
- Regulating Marijuana Retailers
- Regulating Marijuana Marketing
- Regulating Marijuana Products
- Tools to Support Policy Interventions
- Examples of Interventions for Prevention of Marijuana Use Among Youth
- Environmental Strategies and Programs Described in Chapter 2:
- Lessons Learned
- Programs
- Lessons Learned
- Medical Use: Legal
- Programs
- Lessons Learned
- Resources for Evaluation and Quality Improvement
- Types of Evaluations and Study Designs
- What is CQI?
- Why use CQI?
- What are the steps involved in CQI?
- Outcomes
- Evaluation Resources
- − Examples of evaluation measures was
- − The Performance and Evaluation Ofice
- − Introduction to Program Evaluation for Public Health Programs is a self-study guide
- SAMHSA Staf
- Technical Expert Panel
- Rebecca Ramirez, MPH Public Health Consultant
- Amy Berninger, MPH Abt Associates
The views, opinions, and content of this publication are those of the authors and do not necessarily reflect the views, opinions, or policies of SAMHSA. Nothing in this document constitutes a direct or indirect endorsement by SAMHSA of any non-federal entity’s products, services, or policies, and any reference to any non-federal entity’s products, ...
All material appearing in this publication is in the public domain and may be reproduced or copied without permission from SAMHSA. Citation of the source is appreciated. However, this publication may not be reproduced or distributed for a fee without the specific, written authorization of the Ofice of Communications, SAMHSA.
This publication may be downloaded from http://store.samhsa.gov.
Marijuana use among youth and young adults is a major public health concern. Early youth marijuana use is associated with: Neuropsychological and neurodevelopmental decline Poor school performance Increased school drop-out rates Increased risk for psychotic disorders in adulthood Increased risk for later depression Suicidal ideation or behavior As ...
The Substance Abuse and Mental Health Services Administration (SAMHSA), and specifically, its National Mental Health and Substance Use Policy Laboratory (Policy Lab), is pleased to fulfill the charge of the 21st Century Cures Act to disseminate information on evidence-based practices and service delivery models to prevent substance misuse and help ...
Plant form or “flower”: The most known form of marijuana; the dried flowers of the cannabis plant. Sinsemilla: Seedless flowers from unfertilized female plants; contain more THC than other marijuana plant parts or fertilized flowers. Hashish: Historically produced by a manual process of compressing dried cannabis flowers through screens to amass tr...
here and here. Specific pharmaceutical CBD and THC formulations have approval from the U.S. Food and Drug Administration (FDA) for the treatment of defined health conditions. For example, these include seizures, nausea from cancer treatments, and acquired immunodeficiency syndrome (AIDS) wasting syndrome. The following FDA-approved medications are ...
Several factors place some youth at higher risk of initiating and continuing marijuana use, while other factors protect them from adopting this behavior. Both types of factors are present at multiple levels across the socio-ecological model (SEM), including those with a direct efect on an individual as well as indirect neighborhood and community fa...
American Academy of Pediatrics (APP): “In states that have legalized marijuana for recreational purposes, the AAP strongly recommends strict enforcement of rules and regulations that limit access and marketing and advertising to youth... Although the AAP does not condone state laws that allow the sale of marijuana products, in states where recreati...
Substance use prevention programs seek to promote positive youth development and build social-emotional, refusal, self-eficacy, and other skills to reduce marijuana initiation and use. Environmental strategies aim to change or influence community conditions, systems, and policies. The interventions included in this chapter should not be considered ...
Prevention is most efective when interventions are matched to the target population’s level of risk and needs. To determine risk and needs, community coalitions and prevention organizations conduct a community needs assessment using available data to identify gaps in preventive eforts and the risk and protective factors that influence substance use...
This evidence review identified research studies for alcohol, tobacco, and marijuana. Although the body of research around youth prevention with marijuana-related outcomes is growing, clinicians continue to face the challenge of limited evidence, particularly from well-designed randomized controlled trials (RCTs), when selecting programs to address...
There is an extensive body of literature demonstrating the efectiveness of substance use prevention programs for reducing youth tobacco, alcohol, and other drug use. Many of these interventions focus on positive youth development and building social-emotional, refusal, self-eficacy, and similar skills. The evidence behind these interventions has be...
Community-level interventions focus on the entire population or a specific population segment within a country, state, county, or city. Environmental strategies attempt to change social norms and attitudes, systems, and economic conditions to influence behavior and reduce marijuana use. States considering legalizing marijuana may want to establish ...
Marijuana products with added synthetic flavors and odors (such as fruit and candy) may be particularly attractive to youth. These products, typically flavored for inhalation, include vapes and flavored wrappers for combusted products like blunts. Additionally, strains and products may be named as if they were flavored (e.g., mango vapes, Cherry Pi...
Several frameworks and guidelines provide insight into how to plan for, select, and implement programs and policies that will meet prevention needs and produce desired outcomes. SAMHSA’s Strategic Prevention Framework (SPF) provides a comprehensive, five-step approach for understanding and addressing youth marijuana use prevention within states and...
• Gaining support from school administrators, school district oficials, health administrators, healthcare professionals, child advocacy groups, parent associations, and city or county oficials to implement a marijuana prevention policy or program is critical to success. Every intervention needs one or more champions.
• Identify the most relevant champions for each community. Champions may include parents, educators, community members, and youth themselves, who can all educate policy and decision makers about evidence-based prevention strategies. These stakeholders should be engaged in the process early and often for the best efect. Appeals to stakeholders and p...
• Obtaining and sustaining program funding for materials, training resources, and staf eforts is a common challenge. Often, limited funding is available for prevention eforts and resources are stretched thin. Environmental and regulatory strategies may have the advantage of being low cost, or even of generating revenue in the case of taxes.
From the very beginning of any intervention planning, it is important to estimate costs and develop a budget, being sure to include time and costs related to relationship development, capacity building, staf training, evaluation, and other necessary implementation components. A comprehensive plan should address and allocate resources to implement, ...
Once a state, community, or organization has selected a program or policy to address marijuana use, stakeholders can use several strategies to support implementation eforts and address potential challenges and barriers.
• Given the scarcity of data on marijuana-specific prevention programs, the efectiveness of these interventions among various populations or among individuals with diferent demographic characteristics is limited. Since marijuana use rates vary in communities by demographics, such as age, race/ethnicity, and sexual orientation, programs may require ...
• As communities consider implementing programs or policies, stakeholders may have questions about how to adapt the model to their specific circumstances, while still maintaining fidelity to the core elements of the intervention. Fidelity is the degree to which a program delivers an intervention as intended and must be maintained for desired outcom...
There is a large body of implementation science research that examines the tension between adaptation and fidelity, and the importance of balancing the two.5-6 One approach is to develop intervention-specific descriptors for the components essential for fidelity, and what adaptations may be allowed.5 Another approach is to develop hybrid prevention...
• It is vital that staf are properly trained for successful program implementation and to build program capacity. However, this may be dificult to achieve due to staf turnover and limited time for existing staf to become familiar with the program.
• When preparing to implement an intervention, organizations and communities must ensure staf have access to ongoing support and training on the program. Additionally, it is valuable to know broader marijuana regulatory and policy context to understand the environment in which the program is operating. Throughout the life of the program, additional...
Anna Garner Abt Associates Margaret Gwaltney, MBA Abt Associates* Abt Associates Caroline Kupersmith Daniel Jeferson Smith Abt Associates Alicia C. Sparks, PhD, MPH Abt Associates*
Anna Garner Abt Associates Margaret Gwaltney, MBA Abt Associates* Abt Associates Caroline Kupersmith Daniel Jeferson Smith Abt Associates Alicia C. Sparks, PhD, MPH Abt Associates*
Anna Garner Abt Associates Margaret Gwaltney, MBA Abt Associates* Abt Associates Caroline Kupersmith Daniel Jeferson Smith Abt Associates Alicia C. Sparks, PhD, MPH Abt Associates*
Anna Garner Abt Associates Margaret Gwaltney, MBA Abt Associates* Abt Associates Caroline Kupersmith Daniel Jeferson Smith Abt Associates Alicia C. Sparks, PhD, MPH Abt Associates*
Anna Garner Abt Associates Margaret Gwaltney, MBA Abt Associates* Abt Associates Caroline Kupersmith Daniel Jeferson Smith Abt Associates Alicia C. Sparks, PhD, MPH Abt Associates*
Anna Garner Abt Associates Margaret Gwaltney, MBA Abt Associates* Abt Associates Caroline Kupersmith Daniel Jeferson Smith Abt Associates Alicia C. Sparks, PhD, MPH Abt Associates*
Anna Garner Abt Associates Margaret Gwaltney, MBA Abt Associates* Abt Associates Caroline Kupersmith Daniel Jeferson Smith Abt Associates Alicia C. Sparks, PhD, MPH Abt Associates*
Anna Garner Abt Associates Margaret Gwaltney, MBA Abt Associates* Abt Associates Caroline Kupersmith Daniel Jeferson Smith Abt Associates Alicia C. Sparks, PhD, MPH Abt Associates*
Anna Garner Abt Associates Margaret Gwaltney, MBA Abt Associates* Abt Associates Caroline Kupersmith Daniel Jeferson Smith Abt Associates Alicia C. Sparks, PhD, MPH Abt Associates*
Anna Garner Abt Associates Margaret Gwaltney, MBA Abt Associates* Abt Associates Caroline Kupersmith Daniel Jeferson Smith Abt Associates Alicia C. Sparks, PhD, MPH Abt Associates*
Anna Garner Abt Associates Margaret Gwaltney, MBA Abt Associates* Abt Associates Caroline Kupersmith Daniel Jeferson Smith Abt Associates Alicia C. Sparks, PhD, MPH Abt Associates*
Anna Garner Abt Associates Margaret Gwaltney, MBA Abt Associates* Abt Associates Caroline Kupersmith Daniel Jeferson Smith Abt Associates Alicia C. Sparks, PhD, MPH Abt Associates*
Anna Garner Abt Associates Margaret Gwaltney, MBA Abt Associates* Abt Associates Caroline Kupersmith Daniel Jeferson Smith Abt Associates Alicia C. Sparks, PhD, MPH Abt Associates*
Anna Garner Abt Associates Margaret Gwaltney, MBA Abt Associates* Abt Associates Caroline Kupersmith Daniel Jeferson Smith Abt Associates Alicia C. Sparks, PhD, MPH Abt Associates*
Anna Garner Abt Associates Margaret Gwaltney, MBA Abt Associates* Abt Associates Caroline Kupersmith Daniel Jeferson Smith Abt Associates Alicia C. Sparks, PhD, MPH Abt Associates*
Anna Garner Abt Associates Margaret Gwaltney, MBA Abt Associates* Abt Associates Caroline Kupersmith Daniel Jeferson Smith Abt Associates Alicia C. Sparks, PhD, MPH Abt Associates*
Anna Garner Abt Associates Margaret Gwaltney, MBA Abt Associates* Abt Associates Caroline Kupersmith Daniel Jeferson Smith Abt Associates Alicia C. Sparks, PhD, MPH Abt Associates*
Anna Garner Abt Associates Margaret Gwaltney, MBA Abt Associates* Abt Associates Caroline Kupersmith Daniel Jeferson Smith Abt Associates Alicia C. Sparks, PhD, MPH Abt Associates*
Anna Garner Abt Associates Margaret Gwaltney, MBA Abt Associates* Abt Associates Caroline Kupersmith Daniel Jeferson Smith Abt Associates Alicia C. Sparks, PhD, MPH Abt Associates*
Anna Garner Abt Associates Margaret Gwaltney, MBA Abt Associates* Abt Associates Caroline Kupersmith Daniel Jeferson Smith Abt Associates Alicia C. Sparks, PhD, MPH Abt Associates*
Anna Garner Abt Associates Margaret Gwaltney, MBA Abt Associates* Abt Associates Caroline Kupersmith Daniel Jeferson Smith Abt Associates Alicia C. Sparks, PhD, MPH Abt Associates*
Anna Garner Abt Associates Margaret Gwaltney, MBA Abt Associates* Abt Associates Caroline Kupersmith Daniel Jeferson Smith Abt Associates Alicia C. Sparks, PhD, MPH Abt Associates*
Anna Garner Abt Associates Margaret Gwaltney, MBA Abt Associates* Abt Associates Caroline Kupersmith Daniel Jeferson Smith Abt Associates Alicia C. Sparks, PhD, MPH Abt Associates*
Anna Garner Abt Associates Margaret Gwaltney, MBA Abt Associates* Abt Associates Caroline Kupersmith Daniel Jeferson Smith Abt Associates Alicia C. Sparks, PhD, MPH Abt Associates*
Anna Garner Abt Associates Margaret Gwaltney, MBA Abt Associates* Abt Associates Caroline Kupersmith Daniel Jeferson Smith Abt Associates Alicia C. Sparks, PhD, MPH Abt Associates*
Anna Garner Abt Associates Margaret Gwaltney, MBA Abt Associates* Abt Associates Caroline Kupersmith Daniel Jeferson Smith Abt Associates Alicia C. Sparks, PhD, MPH Abt Associates*
Anna Garner Abt Associates Margaret Gwaltney, MBA Abt Associates* Abt Associates Caroline Kupersmith Daniel Jeferson Smith Abt Associates Alicia C. Sparks, PhD, MPH Abt Associates*
Anna Garner Abt Associates Margaret Gwaltney, MBA Abt Associates* Abt Associates Caroline Kupersmith Daniel Jeferson Smith Abt Associates Alicia C. Sparks, PhD, MPH Abt Associates*
Anna Garner Abt Associates Margaret Gwaltney, MBA Abt Associates* Abt Associates Caroline Kupersmith Daniel Jeferson Smith Abt Associates Alicia C. Sparks, PhD, MPH Abt Associates*
Anna Garner Abt Associates Margaret Gwaltney, MBA Abt Associates* Abt Associates Caroline Kupersmith Daniel Jeferson Smith Abt Associates Alicia C. Sparks, PhD, MPH Abt Associates*
Anna Garner Abt Associates Margaret Gwaltney, MBA Abt Associates* Abt Associates Caroline Kupersmith Daniel Jeferson Smith Abt Associates Alicia C. Sparks, PhD, MPH Abt Associates*
Anna Garner Abt Associates Margaret Gwaltney, MBA Abt Associates* Abt Associates Caroline Kupersmith Daniel Jeferson Smith Abt Associates Alicia C. Sparks, PhD, MPH Abt Associates*
Anna Garner Abt Associates Margaret Gwaltney, MBA Abt Associates* Abt Associates Caroline Kupersmith Daniel Jeferson Smith Abt Associates Alicia C. Sparks, PhD, MPH Abt Associates*
Anna Garner Abt Associates Margaret Gwaltney, MBA Abt Associates* Abt Associates Caroline Kupersmith Daniel Jeferson Smith Abt Associates Alicia C. Sparks, PhD, MPH Abt Associates*
Anna Garner Abt Associates Margaret Gwaltney, MBA Abt Associates* Abt Associates Caroline Kupersmith Daniel Jeferson Smith Abt Associates Alicia C. Sparks, PhD, MPH Abt Associates*
2 days ago · Substance use (SU) has long been a significant cause of morbidity and mortality in adolescents and young adults (AYAs) worldwide, with the United States accounting for more than half of drug overdoses internationally prior to the COVID-19 pandemic (hereafter, “COVID”) [1]. In the wake of COVID, however, SU epidemiology has shifted dramatically. Driven by the ubiquity of illicitly ...
KEY MESSAGES. Previous research documents the potential for early adolescent primary prevention interventions to reduce the onset of prescription opioid misuse, and multiple studies document that primary prevention can reduce the onset of misuse of other substances.
Oct 19, 2021 · Medicaid and the Children’s Health Insurance Program (CHIP) serve as critical sources of coverage for children and youth, covering nearly 39 million children nationwide and...
